Preview: Lifecore Biomedical's Earnings
Portfolio Pulse from Benzinga Insights
Lifecore Biomedical (NASDAQ:LFCR) is set to release its latest quarterly earnings report on June 1, 2023. Analysts estimate an EPS of $-0.13. Last quarter, the company missed EPS by $0.27, followed by a 67.32% drop in share price. Shares are currently trading at $8.01 and are down 12.6% over the last 52-week period.
May 31, 2023 | 4:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Lifecore Biomedical's upcoming earnings report on June 1, 2023, has analysts estimating an EPS of $-0.13. Last quarter, the company missed EPS by $0.27, causing a 67.32% drop in share price.
Lifecore Biomedical's upcoming earnings report is expected to show a negative EPS, and the company has a history of missing EPS estimates, which led to a significant drop in share price last quarter. This could negatively impact the stock price in the short term if the company misses estimates again or provides weak guidance.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100